Further work is now required, with a much larger donor group, to quantify the levels of the MMP2 species, and to evaluate the extent to which dysregulation of the MMP system affects the degradation potential towards β-amyloid in Alzheimer's disease. Here, MMP2 is linked to early-onset autosomal dominant Alzheimer disease.